These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25447674)

  • 1. Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.
    Wang X; He H; Lu Y; Ren W; Teng KY; Chiang CL; Yang Z; Yu B; Hsu S; Jacob ST; Ghoshal K; Lee LJ
    Biochim Biophys Acta; 2015 Jan; 1853(1):244-53. PubMed ID: 25447674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
    Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y; Xue JL; Shen Q; Chen J; Tian L
    Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.
    Kumarswamy R; Volkmann I; Jazbutyte V; Dangwal S; Park DH; Thum T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):361-9. PubMed ID: 22095988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
    Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
    J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
    Tu K; Liu Z; Yao B; Han S; Yang W
    Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway.
    Hui Y; Jin D; Leng J; Liu D; Yuan P; Tang C; Wang Q
    Pathol Res Pract; 2022 Jan; 229():153692. PubMed ID: 34847369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
    Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM; Yang H; Fang F; Xu JF; Yang LY
    Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-carbinol inhibits cell proliferation and induces apoptosis in Hep-2 laryngeal cancer cells.
    Wang YQ; Chen C; Chen Z; Xu Y; Wang Y; Xiao BK; Chen SM; Tao ZZ
    Oncol Rep; 2013 Jul; 30(1):227-33. PubMed ID: 23604413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells.
    Rahman KM; Li Y; Sarkar FH
    Nutr Cancer; 2004; 48(1):84-94. PubMed ID: 15203382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
    Qadir XV; Han C; Lu D; Zhang J; Wu T
    Am J Pathol; 2014 Aug; 184(8):2355-64. PubMed ID: 24911372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
    Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
    Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.
    Lin H; Huang ZP; Liu J; Qiu Y; Tao YP; Wang MC; Yao H; Hou KZ; Gu FM; Xu XF
    Sci Rep; 2018 Jul; 8(1):10461. PubMed ID: 29992971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells.
    Higashi T; Hayashi H; Ishimoto T; Takeyama H; Kaida T; Arima K; Taki K; Sakamoto K; Kuroki H; Okabe H; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
    Br J Cancer; 2015 Jul; 113(2):252-8. PubMed ID: 26125451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PTEN/Akt signaling and oxidative stress on indole-3-carbinol (I3C)-induced hepatocarcinogenesis in rats.
    Yamamoto R; Shimamoto K; Ishii Y; Kimura M; Fujii Y; Morita R; Suzuki K; Shibutani M; Mitsumori K
    Exp Toxicol Pathol; 2013 Sep; 65(6):845-52. PubMed ID: 23290887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticarcinogenic effect of indole-3-carbinol (I3C) on human hepatocellular carcinoma SNU449 cells.
    Lee CM; Park SH; Nam MJ
    Hum Exp Toxicol; 2019 Jan; 38(1):136-147. PubMed ID: 29992829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.